Copyright © 1998 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 63, Issue 3, 703-710, 1 September 1998
doi:10.1086/302010
Karin Gaudenz1, Erich Roessler1, 3, Nandita Quaderi4, Brunella Franco4, George Feldman1, David L. Gasser2, Bärbel Wittwer6, Eugenio Montini4, John M. Opitz7, Andrea Ballabio4, 5 and Maximilian Muenke1, 2, 3,
, 
1 Department of Pediatrics, Philadelphia
2 Department of Genetics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia
3 Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
4 Telethon Institute of Genetics and Medicine, Milan
5 Università Vita Salute, Milan
6 Institut für Humangenetik, Westfälische Wilhelms-Universität, Münster, Germany
7 Department of Pediatrics, Human Genetics, and Obstetrics and Gynecology, University of Utah, Salt Lake City
Address for correspondence and reprints: Dr. Maximilian Muenke, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, MSC 1852, Building 10, 10C101, Bethesda, MD 20892-1852Abstract
The MID1 gene in Xp22 codes for a novel member of proteins containing a RING finger, B-box, coiled-coil and a conserved C-terminal domain. Initially, three mutations in the C-terminal region were found in patients with Opitz G/BBB syndrome, a defect of midline development. Here we have determined the complete gene structure of the MID1 gene and have analyzed all nine exons for mutations in a set of 40 unrelated Opitz G/BBB patients. We now report six additional mutations all clustered in the carboxy-terminal domain of the MID1 protein. These data suggest that this conserved domain of the B-box proteins may play a fundamental role in the pathogenesis of Opitz syndrome and in morphogenetic events at the midline during blastogenesis.
| Mapping of a New SGBS Locus to Chromosome Xp22 in a Family with a Severe Form of Simpson-Golabi-Behmel Syndrome The American Journal of Human Genetics, Volume 65, Issue 3, 1 September 1999, Pages 779-783 L.M. Brzustowicz, S. Farrell, M.B. Khan and R. Weksberg Abstract Summary:
Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked overgrowth syndrome with associated visceral and skeletal abnormalities. Alterations in the glypican-3 gene (GPC3), which is located on Xq26, have been implicated in the etiology of relatively milder cases of this disorder. Not all individuals with SGBS have demonstrated disruptions of the GPC3 locus, which raises the possibility that other loci on the X chromosome could be responsible for some cases of this syndrome. We have previously described a large family with a severe form of SGBS that is characterized by multiple anomalies, hydrops fetalis, and death within the first 8 wk of life. Using 25 simple tandem-repeat polymorphism markers spanning the X chromosome, we have localized the gene for this disorder to an ∼6-Mb region of Xp22, with a maximum LOD score of 3.31 and with LOD scores <−2.0 for all of Xq. These results demonstrate that neither the GPC3 gene nor other genes on Xq26 are responsible for all cases of SGBS and that a second SGBS locus resides on Xp22. Abstract | | |
| A 22q11.2 Deletion That Excludes UFD1L and CDC45L in a Patient with Conotruncal and Craniofacial Defects The American Journal of Human Genetics, Volume 65, Issue 2, 1 August 1999, Pages 562-566 Sulagna C. Saitta, James M. McGrath, Holly Mensch, Tamim H. Shaikh, Elaine H. Zackai and Beverly S. Emanuel | |